3 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
Follow Rett Syndrome: new trials by email Literature Review of Rett Syndrome trials Research Report on Rett Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of VYNT-0126 in the Treatment of Rett Syndrome in Adult Patients VYNT-0126, Placebo - Rett Syndrome | Phase 2 | Unknown | Vyant Bio | 48 | 2023-03-01 | 2022-11-23 |
| Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome. Tridecanoic Acid - Rett Syndrome | Phase 2 | Unknown | Sheba Medical Center | 10 | 2017-04-01 | 2017-02-23 |
| Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin triheptanoin - Rett Syndrome | Phase 2 | Unknown | Center for Rare Neurological Diseases, Norcross, GA | 12 | 2016-06-01 | 2020-07-17 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Genetic Diseases, X-Linked (3) · Heredodegenerative Disorders, Nervous System (3) · Intellectual Disability (3) · Nervous System Diseases (3) · Neurobehavioral Manifestations (3) · Neurologic Manifestations (3) · X-Linked Intellectual Disability (3) · Digestive System Diseases (1)
triheptanoin (2)
Center for Rare Neurological Diseases, Norcross, GA (1) · Sheba Medical Center (1) · Vyant Bio (1)
United States (1)
Bruria Ben-Zeev, MD (1) · Daniel Tarquinio, DO (1)